AntibodySystem는 Primary Antibody Biosimilar - Research Grade
제품을 전문적으로 생산하는 20년의 경험이 있는 High Quality 제조사입니다.
제품 설명
Research Grade Glofitamab
제품 번호
DHC90714
제품 특징
Glofitamab is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab is an investigational, T-cell bispecific antibody with a distinctive design that features 2 Fab arms for binding CD20 on B cells, along with 1 Fab arm for binding CD3 on T cells. The CD3 binding arm is fused directly to one of the CD20-binding arms in a head-to-tail fashion via a short flexible linker.
DHC90714
Humanized
Human
Liquid
0.01M PBS, pH 7.4.
1.06 mg/ml
>95% by SDS-PAGE.
Monoclonal
IgG1-kappa-lambda
Research Grade Biosimilar
B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Protein A or G purified from cell culture supernatant.
Please contact with the lab for this information.
XtenCHO
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Bispecific, CD20-TCB (2:1), RG-6026, CAS: 2229047-91-8
For research use only. Not suitable for clinical or therapeutic use.
Data Image
AntibodySystem의 모든 제품들을 만나 보세요!